Innovative inhaler: the Novolizer
On the global market
The Novolizer is now on sale on the global market and the number of asthma and COPD drugs for which it can be used will soon be increased. Various pharmaceutical companies are involved in its further development. In addition, De Boer and Frijlink and their team of specialists are currently working on a special disposable inhaler (the Twincer) for administering drugs for conditions such as cystic fibrosis and tuberculosis. The pharmaceutical industry is already keenly anticipating this new inhaler, as it is also suitable for administering flu jabs and vaccinations against various other infectious diseases. It is thought that the Twincer will be available for use by patients in just a few years.
On 21 April 2010, Anne de Boer and Erik Frijlink were awarded the Wubbo Ockels prize for the successful development of this innovative Novolizer inhaler.
Last modified: | 22 May 2018 10.35 a.m. |
More news
-
18 July 2024
Smart robots to make smaller chips
A robotic arm in a factory that repeatedly executes the same movement: that’s a thing of the past, states Ming Cao. Researchers of the University of Groningen are collaborating with high-tech companies to make production processes more autonomous.
-
17 July 2024
Veni-grants for ten researchers
The Dutch Research Council (NWO) has awarded a Veni grant of up to €320,000 each to ten researchers of the University of Groningen and the UMCG. The Veni grants are designed for outstanding researchers who have recently gained a PhD.
-
15 July 2024
Funding for RUG researchers from National Growth Fund programme Circular Plastics NL
For research on making plastics circular, Professors Patrizio Raffa and Katja Loos together receive about 1.2 million euros from the National Growth Fund programme Circular Plastics NL.